COSMO Pharmaceuticals SA (0RGI) — Capital Reinvestment Ratio
COSMO Pharmaceuticals SA (0RGI) has a Capital Reinvestment Ratio of 2.92x as of June 2025, meaning it reinvests 3% of its operating cash flow (£900.00K) in capital expenditures (£2.62 Million). Check 0RGI tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
COSMO Pharmaceuticals SA Capital Reinvestment Ratio (2004–2024)
This chart tracks COSMO Pharmaceuticals SA's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see 0RGI cash flow metrics.
Annual Capital Reinvestment Ratio for COSMO Pharmaceuticals SA (2004–2024)
Year-by-year Capital Reinvestment Ratio for COSMO Pharmaceuticals SA from 2004 to 2024. See how much free cash does COSMO Pharmaceuticals SA generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBP) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.03x | £162.41 Million | £4.55 Million | ▼ -71.8% |
| 2023 | 0.10x | £33.62 Million | £3.35 Million | ▼ -26.8% |
| 2022 | 0.14x | £32.89 Million | £4.47 Million | ▼ -68.8% |
| 2021 | 0.44x | £12.61 Million | £5.49 Million | ▲ +37.1% |
| 2020 | 0.32x | £12.98 Million | £4.12 Million | ▲ +275.5% |
| 2016 | 0.08x | £21.69 Million | £1.83 Million | ▲ +155.2% |
| 2014 | 0.03x | £66.45 Million | £2.20 Million | ▼ -86.3% |
| 2013 | 0.24x | £8.11 Million | £1.96 Million | ▲ +168.3% |
| 2012 | 0.09x | £27.76 Million | £2.49 Million | ▼ -69.9% |
| 2011 | 0.30x | £11.29 Million | £3.37 Million | ▼ -68.7% |
| 2010 | 0.95x | £7.79 Million | £7.42 Million | ▼ -45.0% |
| 2009 | 1.73x | £3.88 Million | £6.72 Million | ▲ +30.1% |
| 2006 | 1.33x | £6.08 Million | £8.10 Million | ▼ -46.1% |
| 2005 | 2.47x | £1.70 Million | £4.20 Million | ▼ -73.6% |
| 2004 | 9.36x | £261.00K | £2.44 Million | — |